Industry

Consultation and resources available at no cost to local community FRISCO, Texas–(BUSINESS WIRE)–Magellan Health, Inc. today announced that it has opened a complimentary 24-hour crisis line for individuals impacted by the aftermath of Hurricane Ian. The toll-free number to access free, confidential consultation services is 1-800-327-7451. Magellan confidential consultation services are offered at no charge … [Read more…]

First commercially available product to utilize AstreAdept, Astrea Bioseparations’ novel nanofiber-based membrane material CAMBRIDGE, England–(BUSINESS WIRE)–Astrea Bioseparations (“Astrea Bio”), a leading provider of novel purification and separation tools supporting the development of next-generation therapeutics, has announced today the commercial launch of its Nereus LentiHERO™ lentiviral vector (LVV) purification technology. Incorporating AstreAdept™, the Company’s proprietary nanofiber … [Read more…]

The partnership* illustrates Cerba HealthCare’s strategy to support long term health response locally and increase patient access to a broader range of laboratory testing across the continent International Clinical Laboratories (ICL) will leverage the world-class expertise range of Cerba HealthCare and its existing pan-African network Cerba Lancet Africa to sustainably meet the diagnostic tool expectations … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “CROs (Clinical Research Organizations) – Identification, Selection, and Management for Maximum Results & Value” training has been added to ResearchAndMarkets.com’s offering. This CRO training provide all the specific methodology and management techniques to successfully outsource pharmaceutical programs completed on time, within budget, most importantly completed with high level of quality and performance. This … [Read more…]

In addition to supporting the Shriners Children’s Open next week to help families in North America, company sponsors Golf Fights Cancer and GreenLight Fund events to benefit Massachusetts residents DANVERS, Mass.–(BUSINESS WIRE)–#B2Bdata—DemandScience, a global B2B data company that partners with customers to upgrade their sales pipelines, today announced it is sponsoring two events in Massachusetts … [Read more…]

New single API integration lets any EHR service provider enable ADT, adherence data, and interoperability in every customer’s workflow NEW YORK–(BUSINESS WIRE)–Particle Health, a developer-friendly API platform for bi-directional healthcare data exchange, today announced the availability of Particle for EHRs. Particle for EHRs is a new administrative API layer that allows electronic health record (EHR) … [Read more…]

Agreement Expands UC San Diego’s Sanford Stem Cell Institute into an Earth-Space Research Complex Aboard Orbital Reef Space Station LOUISVILLE, Colo.–(BUSINESS WIRE)–Sierra Space, a leading commercial space company at the forefront of building the future of space transportation and infrastructure for low-Earth orbit (LEO) commercialization, and University of California San Diego, one of the world’s … [Read more…]

MC Innovation, CorVel, and Harvard MedTech Will Present a Unique, Immersive Experience Showcasing the Virtual Reality Experience for Treatment LAS VEGAS–(BUSINESS WIRE)–A team of workers’ compensation experts will showcase innovations in mental health treatment with a groundbreaking, experiential presentation at this year’s National Workers’ Compensation and Disability conference. Pearl Monroe, Vice President, MC Innovations, LLC; … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Writing and Enforcing SOPs for FDA-Regulated Industry: Best Practices to Withstand FDA Expectations Course” training has been added to ResearchAndMarkets.com’s offering. This course is intended for all personnel directly involved in the development of standard operating procedures including those responsible for writing validation protocols or execution activities. Beginning or seasoned operational personnel who … [Read more…]

CHICAGO–(BUSINESS WIRE)–MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a targeted therapy, immuno-oncology company focused on developing potential first-in-class oncology drugs, announced today that it will present the results of a study of the anticancer agent 6-thio-dG (THIO) in hepatocellular carcinoma (HCC) in vitro and in vivo models at the EORTC-NCI-AACR (ENA) Symposium on … [Read more…]